The pharmacology of 2,3-bis-(p-methoxyphenyl)-indole (indoxole).

doi:10.1016/s0022-3565(25)27537-1

Paper

The pharmacology of 2,3-bis-(p-methoxyphenyl)-indole (indoxole).

Published Jan 1, 1967 · E. M. Glenn, B. Bowman, W. Kooyers

The Journal of pharmacology and experimental therapeutics

Q2 SJR score

26

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Study Snapshot

Indoxole is a new antiinflammatory drug with a narrower spectrum of activity than hydrocortisone, but comparable to phenylbutazone and more potent than acetylsalicylic acid in preventing and treating rat adjuvant arthritis.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

The pharmacology of 2,3-bis-(p-methoxyphenyl)-indole (indoxole).

References

Citations